{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T13:41:30Z","timestamp":1794663690271,"version":"4.9.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T00:00:00Z","timestamp":1605484800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T00:00:00Z","timestamp":1605484800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p><jats:italic>Streptococcus agalactiae<\/jats:italic>(Group B Streptococcus, GBS) serotypes, sequence types, and antimicrobial resistance profile vary across different geographic locations affecting disease patterns in newborns. These differences are important considerations for vaccine development efforts and data from large countries in Africa is limited. The aim of this study was to determine serotypes and genotypes of GBS isolates from pregnant women and their newborns in Ethiopia.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A hospital based cross-sectional study was conducted at three hospitals in Ethiopia from June 2014 to September 2015. Out of 225 GBS isolates, 121 GBS were recovered, confirmed and characterized at CDC\u2019s Streptococcus Laboratory using conventional microbiology methods and whole genome sequencing.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of the 121 isolates, 87 were from rectovaginal samples of pregnant women, 32 from different body parts of their newborns and 2 from blood of newborns with suspected sepsis. There were 25 mother-infant pairs and 24 pairs had concordant strains. The most prevalent serotypes among mothers and\/or their babies were II, Ia and V (41.5, 20.6, 19.5 and 40.6%, 25 and 15.6%, respectively). Multilocus sequence typing (MLST) on 83 isolates showed ST10 (24; 28.9%) and ST2 (12; 14.5%) as most predominant sequence types. All GBS strains were susceptible to penicillin, cefotaxime and vancomycin, which correlated to the presence of wildtype PBP2x types and the lack of known vancomycin-resistance genes. Tetracycline resistance was high (73; 88%, associated primarily with<jats:italic>tetM<\/jats:italic>, but also<jats:italic>tetO<\/jats:italic>and<jats:italic>tetL)<\/jats:italic>. Five isolates (6%) were resistant to erythromycin and clindamycin and 3 isolates were fluoroquinolone-resistant, containing associated mutations in<jats:italic>gyrA<\/jats:italic>and<jats:italic>parC<\/jats:italic>genes. All isolates were positive for one of four homologous Alpha\/Rib family determinants and 1\u20132 of the three main pilus types.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Predominant serotypes were II, Ia, and V. A limited number of clonal types were identified with two STs accounting for about half of the isolates. All strains collected in this study were susceptible to beta-lactam antibiotics and vancomycin. Typical of most GBS, these isolates were positive for single alpha-like family protein, serine-rich repeat gene, as well as 1\u20132 pilus determinants.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12879-020-05581-8","type":"journal-article","created":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T13:19:15Z","timestamp":1605532755000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Features of Streptococcus agalactiae strains recovered from pregnant women and newborns attending different hospitals in Ethiopia"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7786-3400","authenticated-orcid":false,"given":"Musa Mohammed","family":"Ali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimtubezinash","family":"Woldeamanuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Asrat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Demissie Assegu","family":"Fenta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Beall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Schrag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley","family":"McGee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,16]]},"reference":[{"key":"5581_CR1","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1097\/INF.0000000000001233","volume":"35","author":"A Sinha","year":"2016","unstructured":"Sinha A, Russell LB, Tomczyk S, Verani JR, Schrag SJ, Berkley JA, et al. Disease burden of group B Streptococcus among infants in sub-Saharan Africa: a systematic literature review and meta-analysis. Pediatr Infect Dis J. 2016;35:933\u201342.","journal-title":"Pediatr Infect Dis J"},{"key":"5581_CR2","doi-asserted-by":"publisher","first-page":"S125","DOI":"10.1093\/cid\/cix585","volume":"65","author":"A Seale","year":"2017","unstructured":"Seale A, Blencowe H, Bianchi-Jassir F, Embleton N, Bassat Q, Ordi J, et al. Stillbirth with group B Streptococcus disease worldwide: systematic review and meta-analyses. Clin Infect Dis. 2017;65:S125\u201332.","journal-title":"Clin Infect Dis"},{"key":"5581_CR3","unstructured":"American College of Obstetricians and Gynecologists. Prevention of early-onset Group B Streptococcal disease in newborns. 2019. No. 782. https:\/\/www.acog.org\/GBS."},{"key":"5581_CR4","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1097\/AOG.0000000000000163","volume":"123","author":"JR Verani","year":"2014","unstructured":"Verani JR, Spina NL, Lynfield R, Schaffner W, Harrison LH, Holst A, et al. Early-onset group B streptococcal disease in the United States: potential for further reduction. Obstet Gynecol. 2014;123:828\u201337.","journal-title":"Obstet Gynecol"},{"key":"5581_CR5","doi-asserted-by":"publisher","first-page":"574.e7","DOI":"10.1016\/j.cmi.2017.02.021","volume":"23","author":"BJ Metcalf","year":"2017","unstructured":"Metcalf BJ, Chochua S, Gertz RE Jr, Hawkins PA, Ricaldi J, Li Z, et al. Short-read whole genome sequencing for determination of antimicrobial resistance mechanisms and capsular serotypes of current invasive Streptococcus agalactiae recovered in the USA. Clin Microbiol Infect. 2017;23:574.e7\u2013574.","journal-title":"Clin Microbiol Infect"},{"key":"5581_CR6","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1186\/s13104-015-1328-0","volume":"8","author":"JY Bolukaoto","year":"2015","unstructured":"Bolukaoto JY, Monyama CM, Chukwu MO, Lekala SM, Nchabeleng M, Maloba MR, et al. Antibiotic resistance of Streptococcus agalactiae isolated from pregnant women in Garankuwa, South Africa. BMC Res Notes. 2015;8:364.","journal-title":"BMC Res Notes"},{"key":"5581_CR7","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12941-019-0313-1","volume":"18","author":"M Gizachew","year":"2019","unstructured":"Gizachew M, Tiruneh M, Moges F, Tessema B. Streptococcus agalactiae maternal colonization, antibiotic resistance and serotype profiles in Africa: a meta-analysis. Ann Clin Microbiol Antimicrob. 2019;18:14.","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"5581_CR8","doi-asserted-by":"publisher","first-page":"2876","DOI":"10.1016\/j.vaccine.2015.12.072","volume":"34","author":"PT Heath","year":"2016","unstructured":"Heath PT. Status of vaccine research and development of vaccines for GBS. Vaccine. 2016;34:2876\u20139.","journal-title":"Vaccine."},{"issue":"S2","key":"5581_CR9","doi-asserted-by":"publisher","first-page":"S100","DOI":"10.1093\/cid\/cix658","volume":"65","author":"NJ Russell","year":"2017","unstructured":"Russell NJ, Seale AC, O\u2019Driscoll M, O\u2019Sullivan C, Bianchi-Jassir F, Gonzalez-Guarin J, et al. Maternal colonization with group B Streptococcus and serotype distribution worldwide: systematic review and meta-analyses. Clin Infect Dis. 2017;65(S2):S100\u201311.","journal-title":"Clin Infect Dis"},{"key":"5581_CR10","doi-asserted-by":"publisher","first-page":"2530","DOI":"10.1128\/JCM.41.6.2530-2536.2003","volume":"41","author":"N Jones","year":"2003","unstructured":"Jones N, Bohnsack JF, Takahashi S, Oliver KA, Chan MS. Kunst. Multilocus sequence typing system for group B Streptococcus. J Clin Microbiol. 2003;41:2530\u20136.","journal-title":"J Clin Microbiol"},{"key":"5581_CR11","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1016\/j.micinf.2006.02.008","volume":"8","author":"MC Lamy","year":"2006","unstructured":"Lamy MC, Dramsi S, Billoet A, Reglier-Poupet H, Tazi A, Raymond J, et al. Rapid detection of the \u2018highly virulent\u2019 group B Streptococcus ST-17 clone. Microbes Infect. 2006;8:1714\u201322.","journal-title":"Microbes Infect"},{"key":"5581_CR12","doi-asserted-by":"publisher","unstructured":"McGee L, Chochua S, Li Z, Mathis S, Rivers J, Metcalf B, Ryan A, et al. Multistate, population-based distributions of candidate vaccine targets, clonal complexes, and resistance features of invasive Group B Streptococci within the US: 2015\u20132017. Clin Infect Dis. 2020. https:\/\/doi.org\/10.1093\/cid\/ciaa151 [Epub ahead of print].","DOI":"10.1093\/cid\/ciaa151"},{"key":"5581_CR13","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.1128\/JCM.00117-07","volume":"45","author":"HC Slotved","year":"2007","unstructured":"Slotved HC, Kong F, Lambertsen L, Sauer S, Gilbert GL. Serotype IX, a proposed new Streptococcus agalactiaeserotype. J Clin Microbiol. 2007;45:2929\u201336.","journal-title":"J Clin Microbiol"},{"key":"5581_CR14","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1093\/infdis\/jis605","volume":"206","author":"S Bellais","year":"2012","unstructured":"Bellais S, Six A, Fouet A, Longo M, Dmytruk N, Glaser P, et al. Capsular switching in group B streptococcus CC17 hypervirulent clone: a future challenge for polysaccharide vaccine development. J Infect Dis. 2012;206:1745\u201352.","journal-title":"J Infect Dis"},{"key":"5581_CR15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12941-019-0303-3","volume":"18","author":"M Gizachew","year":"2019","unstructured":"Gizachew M, Tiruneh M, Moges F, Adefris M, Tigabu Z, Tessema B. Streptococcus agalactiae from Ethiopian pregnant women; prevalence, associated factors and antimicrobial resistance: alarming for prophylaxis. Ann Clin Microbiol Antimicrob. 2019;18:3.","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"5581_CR16","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1097\/01.inf.0000049347.42983.77","volume":"22","author":"KL O\u2019Brien","year":"2003","unstructured":"O\u2019Brien KL, Nohynek H. World Health Organization Pneumococcal Vaccine Trials Carriage Working Group Report from a WHO Working Group: standard method for detecting upper respiratory carriage of Streptococcus pneumoniae. Pediatr Infect Dis J. 2003;22:e1\u201311 Erratumin:PediatrInfectDisJ. 2011;30(2):185.","journal-title":"Pediatr Infect Dis J"},{"key":"5581_CR17","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.mimet.2009.11.010","volume":"80","author":"M Imperi","year":"2010","unstructured":"Imperi M, Pataracchia M, Alfarone G, Baldassarri L, Orefici G, Creti R. A multiplex PCR assay for the direct identification of the capsular type (Ia to IX) of Streptococcus agalactiae. J Microbiol Methods. 2010;80:212\u20134.","journal-title":"J Microbiol Methods"},{"key":"5581_CR18","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1128\/JB.186.5.1518-1530.2004","volume":"186","author":"EJ Feil","year":"2014","unstructured":"Feil EJ, Li BC, Aanensen DM, Hanage WP, Spratt BG. eBURST: inferring patterns of evolutionary descent among clusters of related bacterial genotypes from multilocus sequence typing data. J Bacteriol. 2014;186:1518\u201330.","journal-title":"J Bacteriol"},{"key":"5581_CR19","volume-title":"Performance standards for antimicrobial susceptibility testing. 24th ed. CLSI supplement M100","author":"Clinical Laboratory Standards Institute","year":"2014","unstructured":"Clinical Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. 24th ed. CLSI supplement M100. Wayne, PA: Clinical and Laboratory Standards Institute; 2014."},{"key":"5581_CR20","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/S1473-3099(15)00484-3","volume":"16","author":"RS Heyderman","year":"2016","unstructured":"Heyderman RS, Madhi SA, French N, et al. Group B Streptococcus vaccination in pregnant women with or without HIV in Africa: a non-randomised phase 2, open-label, multicentre trial. Lancet Infect Dis. 2016;16:546\u201355.","journal-title":"Lancet Infect Dis"},{"key":"5581_CR21","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1159\/000362368","volume":"23","author":"M Brzychczy-Wloch","year":"2014","unstructured":"Brzychczy-Wloch M, Gosiewski T, Bulanda M. Multilocus sequence types of invasive and colonizing neonatal group B streptococci in Poland. Med Princ Pract. 2014;23:323\u201330.","journal-title":"Med Princ Pract"},{"key":"5581_CR22","first-page":"205","volume":"119","author":"L Strakova","year":"2004","unstructured":"Strakova L, Motlova J. Active surveillance of early onset disease due to group B streptococci in new born. J Indian J med Res. 2004;119:205\u20137.","journal-title":"J Indian J med Res"},{"key":"5581_CR23","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12879-020-4776-7","volume":"20","author":"M Gizachew","year":"2020","unstructured":"Gizachew M, Tiruneh M, Moges F, Adefris M, Tigabu Z, Tessema B. Molecular characterization of Streptococcus agalactiae isolated from pregnant women and newborns at the University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia. BMC Infect Dis. 2020;20:35.","journal-title":"BMC Infect Dis"},{"key":"5581_CR24","doi-asserted-by":"publisher","unstructured":"Paoletti LC, Kasper DL. Surface structures of Group B Streptococcus important in human immunity. Microbiol Spectr. 2019;7(2). https:\/\/doi.org\/10.1128\/microbiolspec GPP3-0001-2017.","DOI":"10.1128\/microbiolspec"},{"key":"5581_CR25","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1086\/595564","volume":"199","author":"I Margarit","year":"2009","unstructured":"Margarit I, Rinaudo C, Galeotti C, Maione D, Ghezzo C, Buttazzoni E, et al. Preventing bacterial infections with pilus-based vaccines: the group B streptococcus paradigm. J Infect Dis. 2009;199:108\u201315.","journal-title":"J Infect Dis"},{"key":"5581_CR26","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.chom.2007.10.003","volume":"2","author":"M St\u00e5lhammar-Carlemalm","year":"2007","unstructured":"St\u00e5lhammar-Carlemalm M, Waldemarsson J, Johnsson E, Areschoug T, Lindahl G. Nonimmuno dominant regions are effective as building blocks in a streptococcal fusion protein vaccine. Cell Host Microbe. 2007;2:427\u201334.","journal-title":"Cell Host Microbe"},{"key":"5581_CR27","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1084\/jem.20092594","volume":"207","author":"A Tazi","year":"2010","unstructured":"Tazi A, Disson O, Bellais S, Bouaboud A, Dmytruk N, Dramsi S, et al. The surface protein HvgA mediates group B streptococcus hypervirulence and meningeal tropism in neonates. J Exp Med. 2010;207:2313\u201322.","journal-title":"J Exp Med"},{"key":"5581_CR28","doi-asserted-by":"publisher","first-page":"585","DOI":"10.3201\/eid2014.140759","volume":"21","author":"S Teatero","year":"2015","unstructured":"Teatero S, McGee A, Li A, Gomes J, Seah C, Demczuk W, et al. Population structure and antimicrobial resistance of invasive serotype IV group B Streptococcus, Toronto, Ontario, Canada. Emerg Infect Dis. 2015;21:585\u201391.","journal-title":"Emerg Infect Dis"},{"key":"5581_CR29","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1093\/jac\/dkv022","volume":"70","author":"K Kimura","year":"2015","unstructured":"Kimura K, Nagano N, Arakawa Y. Classification of group B streptococci with reduced \u03b2-lactam susceptibility (GBS-RBS) based on the amino acid substitutions in PBPs. Antimicrob Agents Chemother. 2015;70:1601\u20133.","journal-title":"Antimicrob Agents Chemother"},{"key":"5581_CR30","doi-asserted-by":"publisher","first-page":"414","DOI":"10.3343\/alm.2019.39.4.414","volume":"39","author":"A Yi","year":"2019","unstructured":"Yi A, Kim CK, Kimura K, Arakawa Y, Hur M, Yun YM, et al. First case in Korea of Group B Streptococcus with reduced penicillin susceptibility harboring amino acid substitutions in penicillin-binding protein 2X. Ann Lab Med. 2019;39:414\u20136.","journal-title":"Ann Lab Med"},{"key":"5581_CR31","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1186\/s13104-016-2158-4","volume":"9","author":"A Mengist","year":"2016","unstructured":"Mengist A, Kannan H, Abdissa A. Prevalence and antimicrobial susceptibility pattern of anorectal and vaginal group B streptococci isolates among pregnant women in Jimma, Ethiopia. BMC Res Notes. 2016;9:351.","journal-title":"BMC Res Notes"},{"key":"5581_CR32","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12884-018-1791-4","volume":"18","author":"S Assefa","year":"2018","unstructured":"Assefa S, Desta K, Lema T. Group B streptococci vaginal colonization and drug susceptibility pattern among pregnant women attending in selected public antenatal care centers in Addis Ababa, Ethiopia. BMC Pregnancy and Childbirth. 2018;18:135.","journal-title":"BMC Pregnancy and Childbirth"},{"key":"5581_CR33","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1093\/jac\/dkx077","volume":"72","author":"PA Hawkins","year":"2017","unstructured":"Hawkins PA, Law CS, Metcalf BJ, Chochua S, Jackson DM, Westblade LF, et al. Cross-resistance to lincosamides, streptogramins a and pleuromutilins in Streptococcus agalactiae isolates from the USA. J Antimicrob Chemother. 2017;72:1886\u201392.","journal-title":"J Antimicrob Chemother"},{"key":"5581_CR34","doi-asserted-by":"publisher","first-page":"4544.10","DOI":"10.1038\/ncomms5544","volume":"5","author":"V Da Cunha","year":"2014","unstructured":"Da Cunha V, Davies MR, Douarre PE, Rosinski-Chupin I, Margarit I, Spinali S, et al. Streptococcus agalactiae clones infecting humans were selected and fixed through the extensive use of tetracycline. Nat Commun. 2014;5:4544.10.","journal-title":"Nat Commun"},{"key":"5581_CR35","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1128\/AAC.00035-08","volume":"52","author":"H-M Wu","year":"2008","unstructured":"Wu H-M, Janapatla R, Wu C-W, Yan J-J, Ho Y-R, Wu J-J, Hung K-H. Emergence of fluoroquinolone resistance in Group B Streptococcal isolates in Taiwan. Antimicrob Agents Chemother. 2008;52:1888\u201390.","journal-title":"Antimicrob Agents Chemother"},{"key":"5581_CR36","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1128\/AAC.05127-14","volume":"59","author":"G Piccinelli","year":"2015","unstructured":"Piccinelli G, Gargiulo F, Corbellini S, Ravizzola G, Bonfanti C, Caruso A, et al. Emergence of the first levofloxacin-resistant strains of Streptococcus agalactiae isolated in Italy. Antimicrob Agents Chemother. 2015;59:2466\u20139.","journal-title":"Antimicrob Agents Chemother"},{"key":"5581_CR37","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1590\/S0074-02762011000200001","volume":"106","author":"P Nakamura","year":"2011","unstructured":"Nakamura P, Schuab R, Neves F, Pereira C, Paula C, Barros R. Antimicrobial resistance profiles and genetic characterisation of macrolide resistant isolates of Streptococcus agalactiae. Mem Inst Oswaldo Cruz. 2011;106:119\u201322.","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"5581_CR38","doi-asserted-by":"publisher","first-page":"e0183083","DOI":"10.1371\/journal.pone.0183083","volume":"12","author":"W Ji","year":"2017","unstructured":"Ji W, Zhang L, Guo Z, Xie S, Yang W, Chen J, et al. Colonization prevalence and antibiotic susceptibility of Group B Streptococcus in pregnant women over a 6-year period in Dongguan, China. PLoS ONE. 2017;12:e0183083.","journal-title":"PLoS ONE"},{"key":"5581_CR39","doi-asserted-by":"publisher","first-page":"6403928","DOI":"10.1155\/2016\/6403928","volume":"2016","author":"A Neemuchwala","year":"2016","unstructured":"Neemuchwala A, Teatero S, Patel S, Fittipaldi N. Fluoroquinolone resistance among clonal complex 1 group B Streptococcus strains. Canadian J Infect Dis Med Microbiol. 2016;2016:6403928.","journal-title":"Canadian J Infect Dis Med Microbiol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05581-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-020-05581-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05581-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,28]],"date-time":"2022-11-28T06:46:36Z","timestamp":1669617996000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-020-05581-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,16]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5581"],"URL":"https:\/\/doi.org\/10.1186\/s12879-020-05581-8","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,16]]},"assertion":[{"value":"25 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Institutional Review Board of the College of Health Sciences, Addis Ababa University (Ref No:069\/13\/DMIP) and the National Ethics and Research Committee (Ref No: 3.10\/795\/06). Written informed consent was obtained from all study participants to further characterize the <i>S. agalactiae<\/i> obtained from them and their newborn. CDC provided support only for characterization of blinded GBS isolates. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the CDC.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The Authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"848"}}